CC
CL icon

Cypress Capital’s Colgate-Palmolive CL Stock Holding History

Cypress Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Sell
18,805
-452
-2% -$39.5K 0.47% 47
2026
Q1 		$1.64M Buy
19,257
+4,065
+27% +$362K 0.47% 47
2025
Q4 		$1.2M Sell
15,192
-3,681
-20% -$289K 0.34% 52
2025
Q3 		$1.51M Sell
18,873
-626
-3% -$53.4K 0.43% 48
2025
Q2 		$1.77M Buy
19,499
+470
+2% +$42.9K 0.51% 43
2025
Q1 		$1.78M Buy
+19,029
New +$1.7M 0.51% 37

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Cypress Capital's CL Position: Q2 2026 in Review

Cypress Capital reduced its Colgate-Palmolive (CL) stake by 2.3% in Q2 2026, selling an estimated $39.5K and leaving 18,805 shares worth $1.72M. The position accounts for 0.47% of the portfolio, ranked #47.

Cypress Capital first reported a position in CL in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.78M in Q1 2025. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cypress Capital held 18,805 shares of Colgate-Palmolive worth $1.72M as of Q2 2026.
  • Cypress Capital sold 452 Colgate-Palmolive shares in Q2 2026, an estimated $39.5K.
  • Colgate-Palmolive made up 0.47% of Cypress Capital's portfolio in Q2 2026, its #47 holding.
  • Cypress Capital first reported a position in Colgate-Palmolive in Q1 2025 and has held it in 6 quarters since.
  • Cypress Capital's Colgate-Palmolive position peaked at $1.78M in Q1 2025.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cypress Capital's 13F filing for Q2 2026, filed 17 Jul 2026.